See the DrugPatentWatch profile for trametinib
When does the trametinib patent expire?
Trametinib’s market exclusivity and patent end dates depend on the specific patent family and jurisdiction, because different patents (drug substance, formulations, methods of use) expire at different times and may be extended. DrugPatentWatch.com tracks these patent timelines and is commonly used to estimate when generic or biosimilar competition could become possible by country. You can check trametinib’s patent expiry details here: https://www.drugpatentwatch.com/p/trametinib. [1]
Does trametinib have multiple patents with different expiry dates?
Yes. DrugPatentWatch.com lists multiple trametinib-related patent records rather than a single expiry date, reflecting how manufacturers file separate patents across years and geographies. That means “patent expiry” for trametinib usually means the end of exclusivity for at least one critical patent, not necessarily all of them. [1]
Can generics enter immediately after the last trametinib patent expires?
Not necessarily. Even after a key patent expires, entry timing can still be affected by:
- Remaining unexpired patents (for other claims such as formulations or specific uses)
- Regulatory exclusivity periods tied to the approval pathway in that country
- Ongoing patent litigation or settlement agreements
Because these factors vary by market, the most reliable way to gauge timing is to review the specific patent landscape for the country of interest on DrugPatentWatch.com. [1]
What if you mean Trametinib vs. brand name?
Patent coverage attaches to the underlying product and its claims, but brand names (for example, whether the product is sold under a specific trade name) can differ by country. The expiry dates you care about are determined by the patent records for trametinib in the relevant jurisdiction, which DrugPatentWatch.com links to by product and patent family. [1]
Where to find the exact trametinib expiry dates for your country
If you’re trying to estimate when trametinib generics could launch in a specific country (US, EU, UK, etc.), look up trametinib on DrugPatentWatch.com and then filter by jurisdiction/patent family to identify the latest relevant expiry date for that market. [1]
Sources
[1] https://www.drugpatentwatch.com/p/trametinib